PET O-15 Imaging Agent Literature Filing Is Inadequate; F-18, N-13 Okayed
Executive Summary
Additional information is needed to support FDA approval for use of water O-15 injection imaging agent to measure cerebral blood flow in patients with cerebral vascular disorders in conjunction with positron emission tomography, FDA's Medical Imaging Drugs Advisory Committee concluded June 29.